News

Pandemic led to profound changes in multiple sclerosis clinical practice

UC Riverside-led national survey of MS specialists finds nearly 10% had been redeployed to the front lines of COVID-19 patient care
By Iqbal Pittalwala | | Health
neurons

Remyelinating drug could improve vision in patients with multiple sclerosis

UC Riverside-led mouse study stresses MS treatment should be started early
By Iqbal Pittalwala | | Health

Researchers explore why some MS patients experience seizures

UC Riverside study examines molecular pathways that may instigate seizures in some multiple sclerosis patients
By Stacy Kish | | Health
Woman in pain perhaps

More than half of American adults with advanced multiple sclerosis report mistreatment by caregivers

UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population
By Iqbal Pittalwala | | Health

Research offers superior therapeutic approach for MS

Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis. While treatments are...
By Stacy Kish | | Health
Hawra Karim (left) and Seema Tiwari-Woodruff

Chemical compound produces beneficial inflammation and remyelination that could help treat multiple sclerosis

UC Riverside-led study shows that ‘good inflammation’ promotes axon myelination
By Iqbal Pittalwala | | Health